Clearmind Medicine Common Stock Performance
| CMND Stock | USD 1.44 0.05 3.36% |
On a scale of 0 to 100, Clearmind Medicine holds a performance score of 3. The firm shows a Beta (market volatility) of 0.36, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, Clearmind Medicine's returns are expected to increase less than the market. However, during the bear market, the loss of holding Clearmind Medicine is expected to be smaller as well. Please check Clearmind Medicine's treynor ratio, expected short fall, and the relationship between the jensen alpha and potential upside , to make a quick decision on whether Clearmind Medicine's price patterns will revert.
Risk-Adjusted Performance
3 of 100
Weak | Strong |
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Clearmind Medicine Common are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of rather uncertain basic indicators, Clearmind Medicine exhibited solid returns over the last few months and may actually be approaching a breakup point. ...more
Last Split Factor 1:30 | Last Split Date 2023-11-28 |
1 | Clearmind Medicine and Dr Glitter Pty Ltd Sign Term Sheet for Mu | 12/16/2024 |
2 | Why Is Penny Stock Clearmind Gaining Today | 12/24/2024 |
3 | Clearmind Medicine Granted Patent for Binge Behavior Treatment by the Macau International Intellectual Property Office | 01/02/2025 |
| Begin Period Cash Flow | 93.5 K |
Clearmind |
Clearmind Medicine Relative Risk vs. Return Landscape
If you would invest 136.00 in Clearmind Medicine Common on October 11, 2024 and sell it today you would earn a total of 8.00 from holding Clearmind Medicine Common or generate 5.88% return on investment over 90 days. Clearmind Medicine Common is currently generating 0.4136% in daily expected returns and assumes 8.5765% risk (volatility on return distribution) over the 90 days horizon. In different words, 76% of stocks are less volatile than Clearmind, and 92% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Clearmind Medicine Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Clearmind Medicine's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Clearmind Medicine Common, and traders can use it to determine the average amount a Clearmind Medicine's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0482
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | CMND | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 8.58 actual daily | 76 76% of assets are less volatile |
Expected Return
| 0.41 actual daily | 8 92% of assets have higher returns |
Risk-Adjusted Return
| 0.05 actual daily | 3 97% of assets perform better |
Based on monthly moving average Clearmind Medicine is performing at about 3% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Clearmind Medicine by adding it to a well-diversified portfolio.
Clearmind Medicine Fundamentals Growth
Clearmind Stock prices reflect investors' perceptions of the future prospects and financial health of Clearmind Medicine, and Clearmind Medicine fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Clearmind Stock performance.
| Return On Equity | -2.68 | ||||
| Return On Asset | -0.58 | ||||
| Current Valuation | (693.24 K) | ||||
| Shares Outstanding | 4.38 M | ||||
| Price To Earning | (750.00) X | ||||
| Price To Book | 1.99 X | ||||
| EBITDA | (8.71 M) | ||||
| Net Income | (6.23 M) | ||||
| Cash And Equivalents | 1.65 K | ||||
| Total Debt | 3.61 M | ||||
| Current Ratio | 0.03 X | ||||
| Book Value Per Share | 0.87 X | ||||
| Cash Flow From Operations | (4.56 M) | ||||
| Earnings Per Share | (1.23) X | ||||
| Market Capitalization | 6.53 M | ||||
| Total Asset | 4.32 M | ||||
| Retained Earnings | (13.63 M) | ||||
| Working Capital | 824.76 K | ||||
About Clearmind Medicine Performance
By analyzing Clearmind Medicine's fundamental ratios, stakeholders can gain valuable insights into Clearmind Medicine's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Clearmind Medicine has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Clearmind Medicine has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (3.24) | (3.41) | |
| Return On Capital Employed | (14.07) | (13.37) | |
| Return On Assets | (3.18) | (3.34) | |
| Return On Equity | (10.08) | (9.58) |
Things to note about Clearmind Medicine Common performance evaluation
Checking the ongoing alerts about Clearmind Medicine for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Clearmind Medicine Common help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Clearmind Medicine had very high historical volatility over the last 90 days | |
| Clearmind Medicine may become a speculative penny stock | |
| Clearmind Medicine has a very high chance of going through financial distress in the upcoming years | |
| Clearmind Medicine Common currently holds 3.61 M in liabilities. Clearmind Medicine Common has a current ratio of 0.03, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about Clearmind Medicine's use of debt, we should always consider it together with its cash and equity. | |
| Net Loss for the year was (6.23 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Clearmind Medicine Common currently holds about 1.65 K in cash with (4.56 M) of positive cash flow from operations. | |
| Clearmind Medicine has a frail financial position based on the latest SEC disclosures | |
| Latest headline from finance.yahoo.com: Clearmind Medicine Granted Patent for Binge Behavior Treatment by the Macau International Intellectual Property Office |
- Analyzing Clearmind Medicine's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Clearmind Medicine's stock is overvalued or undervalued compared to its peers.
- Examining Clearmind Medicine's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Clearmind Medicine's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Clearmind Medicine's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Clearmind Medicine's stock. These opinions can provide insight into Clearmind Medicine's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Clearmind Stock analysis
When running Clearmind Medicine's price analysis, check to measure Clearmind Medicine's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Clearmind Medicine is operating at the current time. Most of Clearmind Medicine's value examination focuses on studying past and present price action to predict the probability of Clearmind Medicine's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Clearmind Medicine's price. Additionally, you may evaluate how the addition of Clearmind Medicine to your portfolios can decrease your overall portfolio volatility.
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |